288 related articles for article (PubMed ID: 30190481)
1. Differentiation therapy and the mechanisms that terminate cancer cell proliferation without harming normal cells.
Enane FO; Saunthararajah Y; Korc M
Cell Death Dis; 2018 Sep; 9(9):912. PubMed ID: 30190481
[TBL] [Abstract][Full Text] [Related]
2. Ultimate Precision: Targeting Cancer but Not Normal Self-replication.
Velcheti V; Schrump D; Saunthararajah Y
Am Soc Clin Oncol Educ Book; 2018 May; 38():950-963. PubMed ID: 30231326
[TBL] [Abstract][Full Text] [Related]
3. Higher-Level Pathway Objectives of Epigenetic Therapy: A Solution to the p53 Problem in Cancer.
Velcheti V; Radivoyevitch T; Saunthararajah Y
Am Soc Clin Oncol Educ Book; 2017; 37():812-824. PubMed ID: 28561650
[TBL] [Abstract][Full Text] [Related]
4. PBRM1 loss in kidney cancer unbalances the proximal tubule master transcription factor hub to repress proximal tubule differentiation.
Gu X; Enane F; Tohme R; Schuerger C; Radivoyevitch T; Parker Y; Zuberi E; Przychodzen B; Jha BK; Lindner D; Rini B; Saunthararajah Y
Cell Rep; 2021 Sep; 36(12):109747. PubMed ID: 34551289
[TBL] [Abstract][Full Text] [Related]
5. GATA4 loss of function in liver cancer impedes precursor to hepatocyte transition.
Enane FO; Shuen WH; Gu X; Quteba E; Przychodzen B; Makishima H; Bodo J; Ng J; Chee CL; Ba R; Seng Koh L; Lim J; Cheong R; Teo M; Hu Z; Ng KP; Maciejewski J; Radivoyevitch T; Chung A; Ooi LL; Tan YM; Cheow PC; Chow P; Chan CY; Lim KH; Yerian L; Hsi E; Toh HC; Saunthararajah Y
J Clin Invest; 2017 Sep; 127(9):3527-3542. PubMed ID: 28758902
[TBL] [Abstract][Full Text] [Related]
6. The Myc oncoprotein as a therapeutic target for human cancer.
Vita M; Henriksson M
Semin Cancer Biol; 2006 Aug; 16(4):318-30. PubMed ID: 16934487
[TBL] [Abstract][Full Text] [Related]
7. Anti-tumor activity of cediranib, a pan-vascular endothelial growth factor receptor inhibitor, in pancreatic ductal adenocarcinoma cells.
Momeny M; Alishahi Z; Eyvani H; Esmaeili F; Zaghal A; Ghaffari P; Tavakkoly-Bazzaz J; Alimoghaddam K; Ghavamzadeh A; Ghaffari SH
Cell Oncol (Dordr); 2020 Feb; 43(1):81-93. PubMed ID: 31512195
[TBL] [Abstract][Full Text] [Related]
8. Prolonged inhibition of hepatocellular carcinoma cell proliferation by combinatorial expression of defined transcription factors.
Takashima Y; Horisawa K; Udono M; Ohkawa Y; Suzuki A
Cancer Sci; 2018 Nov; 109(11):3543-3553. PubMed ID: 30220099
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic modifier directed therapeutics to unleash healthy genes in unhealthy cells.
Jha BK; Saunthararajah Y
Semin Hematol; 2021 Jan; 58(1):1-3. PubMed ID: 33509437
[TBL] [Abstract][Full Text] [Related]
10. An integrative analysis reveals functional targets of GATA6 transcriptional regulation in gastric cancer.
Sulahian R; Casey F; Shen J; Qian ZR; Shin H; Ogino S; Weir BA; Vazquez F; Liu XS; Hahn WC; Bass AJ; Chan V; Shivdasani RA
Oncogene; 2014 Dec; 33(49):5637-48. PubMed ID: 24317510
[TBL] [Abstract][Full Text] [Related]
11. Prognostic relevance of molecular subtypes and master regulators in pancreatic ductal adenocarcinoma.
Janky R; Binda MM; Allemeersch J; Van den Broeck A; Govaere O; Swinnen JV; Roskams T; Aerts S; Topal B
BMC Cancer; 2016 Aug; 16():632. PubMed ID: 27520560
[TBL] [Abstract][Full Text] [Related]
12. Loss of ARID1A Promotes Epithelial-Mesenchymal Transition and Sensitizes Pancreatic Tumors to Proteotoxic Stress.
Tomihara H; Carbone F; Perelli L; Huang JK; Soeung M; Rose JL; Robinson FS; Lissanu Deribe Y; Feng N; Takeda M; Inoue A; Poggetto ED; Deem AK; Maitra A; Msaouel P; Tannir NM; Draetta GF; Viale A; Heffernan TP; Bristow CA; Carugo A; Genovese G
Cancer Res; 2021 Jan; 81(2):332-343. PubMed ID: 33158812
[TBL] [Abstract][Full Text] [Related]
13. Long interspersed nuclear element ORF-1 protein promotes proliferation and resistance to chemotherapy in hepatocellular carcinoma.
Feng F; Lu YY; Zhang F; Gao XD; Zhang CF; Meredith A; Xu ZX; Yang YT; Chang XJ; Wang H; Qu JH; Zeng Z; Yang JL; Wang CP; Zhu YF; Cui JJ; Yang YP
World J Gastroenterol; 2013 Feb; 19(7):1068-78. PubMed ID: 23466962
[TBL] [Abstract][Full Text] [Related]
14. A Yap-Myc-Sox2-p53 Regulatory Network Dictates Metabolic Homeostasis and Differentiation in Kras-Driven Pancreatic Ductal Adenocarcinomas.
Murakami S; Nemazanyy I; White SM; Chen H; Nguyen CDK; Graham GT; Saur D; Pende M; Yi C
Dev Cell; 2019 Oct; 51(1):113-128.e9. PubMed ID: 31447265
[TBL] [Abstract][Full Text] [Related]
15. A Novel MIF Signaling Pathway Drives the Malignant Character of Pancreatic Cancer by Targeting NR3C2.
Yang S; He P; Wang J; Schetter A; Tang W; Funamizu N; Yanaga K; Uwagawa T; Satoskar AR; Gaedcke J; Bernhardt M; Ghadimi BM; Gaida MM; Bergmann F; Werner J; Ried T; Hanna N; Alexander HR; Hussain SP
Cancer Res; 2016 Jul; 76(13):3838-50. PubMed ID: 27197190
[TBL] [Abstract][Full Text] [Related]
16. Identification of MRP4/ABCC4 as a Target for Reducing the Proliferation of Pancreatic Ductal Adenocarcinoma Cells by Modulating the cAMP Efflux.
Carozzo A; Yaneff A; Gómez N; Di Siervi N; Sahores A; Diez F; Attorresi AI; Rodríguez-González Á; Monczor F; Fernández N; Abba M; Shayo C; Davio C
Mol Pharmacol; 2019 Jul; 96(1):13-25. PubMed ID: 31043460
[TBL] [Abstract][Full Text] [Related]
17. Cancer stem cells and differentiation therapy.
Sell S
Tumour Biol; 2006; 27(2):59-70. PubMed ID: 16557043
[TBL] [Abstract][Full Text] [Related]
18. Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma.
Qian Y; Gong Y; Fan Z; Luo G; Huang Q; Deng S; Cheng H; Jin K; Ni Q; Yu X; Liu C
J Hematol Oncol; 2020 Oct; 13(1):130. PubMed ID: 33008426
[TBL] [Abstract][Full Text] [Related]
19. Ubiquitin-specific protease 7 is a druggable target that is essential for pancreatic cancer growth and chemoresistance.
Chen H; Zhu X; Sun R; Ma P; Zhang E; Wang Z; Fan Y; Zhou G; Mao R
Invest New Drugs; 2020 Dec; 38(6):1707-1716. PubMed ID: 32468271
[TBL] [Abstract][Full Text] [Related]
20. Differentiation therapy: targeting human renal cancer stem cells with interleukin 15.
Azzi S; Bruno S; Giron-Michel J; Clay D; Devocelle A; Croce M; Ferrini S; Chouaib S; Vazquez A; Charpentier B; Camussi G; Azzarone B; Eid P
J Natl Cancer Inst; 2011 Dec; 103(24):1884-98. PubMed ID: 22043039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]